Search research articles
Contact Us
Filters
Showing results (21-30 of 37) with videos related to
Page
of 4
Sort By:
European Journal of Pharmacology
|
March 26, 2003
Mechanisms of vasorelaxation to testosterone in the rat aorta
Patcharin Tep-areenan, David A Kendall, Michael D Randall
Pharmacological Research
|
December 3, 2014
Hyperoxic gassing with Tiron enhances bradykinin-induced endothelium-dependent and EDH-type relaxation through generation of hydrogen peroxide
Pui San Wong, Richard E Roberts, Michael D Randall
Pharmacology & Therapeutics
|
August 17, 2002
Cardiovascular effects of cannabinoids
Michael D Randall, David Harris, David A Kendall, et al.
European Journal of Pharmacology
|
December 14, 2011
Hydrogen peroxide as a mediator of vasorelaxation evoked by N-oleoylethanolamine and anandamide in rat small mesenteric arteries
Amanda J Wheal, Stephen P H Alexander, Michael D Randall
European Journal of Pharmacology
|
March 19, 2013
The complex effects of cannabinoids on insulin secretion from rat isolated islets of Langerhans
Richard L Anderson, Michael D Randall, Susan L F Chan
Life Sciences
|
October 2, 2002
Cannabinoid modulation of sensory neurotransmission via cannabinoid and vanilloid receptors: roles in regulation of cardiovascular function
Vera Ralevic, David A Kendall, Michael D Randall, et al.
Frontiers in Pharmacology
|
June 3, 2017
<i>In Vivo</i> Cannabidiol Treatment Improves Endothelium-Dependent Vasorelaxation in Mesenteric Arteries of Zucker Diabetic Fatty Rats
Amanda J Wheal, Khalid Jadoon, Michael D Randall, et al.
The Journal of Physiology
|
March 19, 2002
Characterization of vasorelaxant responses to anandamide in the rat mesenteric arterial bed
David Harris, Audrey I McCulloch, David A Kendall, et al.
European Journal of Pharmacology
|
October 15, 2013
Cannabinoids alter endothelial function in the Zucker rat model of type 2 diabetes
Christopher P Stanley, Amanda J Wheal, Michael D Randall, et al.
Lancet (London, England)
|
February 20, 2007
Rimonabant in obese patients with type 2 diabetes
Michael D Randall, David A Kendall, Andrew J Bennett, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 37) with videos related to
Sort By:
Page
of 4
European Journal of Pharmacology
|
March 26, 2003
Mechanisms of vasorelaxation to testosterone in the rat aorta
Patcharin Tep-areenan, David A Kendall, Michael D Randall
Pharmacological Research
|
December 3, 2014
Hyperoxic gassing with Tiron enhances bradykinin-induced endothelium-dependent and EDH-type relaxation through generation of hydrogen peroxide
Pui San Wong, Richard E Roberts, Michael D Randall
Pharmacology & Therapeutics
|
August 17, 2002
Cardiovascular effects of cannabinoids
Michael D Randall, David Harris, David A Kendall, et al.
European Journal of Pharmacology
|
December 14, 2011
Hydrogen peroxide as a mediator of vasorelaxation evoked by N-oleoylethanolamine and anandamide in rat small mesenteric arteries
Amanda J Wheal, Stephen P H Alexander, Michael D Randall
European Journal of Pharmacology
|
March 19, 2013
The complex effects of cannabinoids on insulin secretion from rat isolated islets of Langerhans
Richard L Anderson, Michael D Randall, Susan L F Chan
Life Sciences
|
October 2, 2002
Cannabinoid modulation of sensory neurotransmission via cannabinoid and vanilloid receptors: roles in regulation of cardiovascular function
Vera Ralevic, David A Kendall, Michael D Randall, et al.
Frontiers in Pharmacology
|
June 3, 2017
<i>In Vivo</i> Cannabidiol Treatment Improves Endothelium-Dependent Vasorelaxation in Mesenteric Arteries of Zucker Diabetic Fatty Rats
Amanda J Wheal, Khalid Jadoon, Michael D Randall, et al.
The Journal of Physiology
|
March 19, 2002
Characterization of vasorelaxant responses to anandamide in the rat mesenteric arterial bed
David Harris, Audrey I McCulloch, David A Kendall, et al.
European Journal of Pharmacology
|
October 15, 2013
Cannabinoids alter endothelial function in the Zucker rat model of type 2 diabetes
Christopher P Stanley, Amanda J Wheal, Michael D Randall, et al.
Lancet (London, England)
|
February 20, 2007
Rimonabant in obese patients with type 2 diabetes
Michael D Randall, David A Kendall, Andrew J Bennett, et al.
Page
of 4